Tumor size, but not consolidation‐to‐tumor ratio, is an independent prognostic factor for part‐solid clinical T1 non‐small cell lung cancer
Abstract Background Tumor size and consolidation‐to‐tumor ratio (CTR) are crucial for non–small cell lung cancer (NSCLC) prognosis. However, the optimal CTR cutoff remains unclear. Whether tumor size and CTR are independent prognostic factors for part‐solid NSCLC is under debate. Here, we aimed to e...
Main Authors: | Zhihua Li, Wenzheng Xu, Tianhao Gu, Xincen Cao, Weibing Wu, Liang Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Thoracic Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1111/1759-7714.14788 |
Similar Items
-
Concurrent lung adenocarcinoma hidden among multiple shadows of COVID‐19 pneumonia: A rare and instructive case report
by: Yoshihiro Kitahara, et al.
Published: (2023-02-01) -
Consolidation-to-tumor ratio is not a prognostic factor for lung cancer manifesting as radiological part-solid nodules
by: Shuangshuang He, et al.
Published: (2024-02-01) -
Research Progress in the Effect of Consolidation Tumor Ratio
on the Diagnosis and Treatment of Early-stage Peripheral Lung Cancer
by: Hanqing HUANG, et al.
Published: (2022-10-01) -
A Parameter and complication to be followed in COVID-19 patients: creatine kinase and rhabdomyolysis
by: Nevsun Pihtili Tas, et al.
Published: (2022-03-01) -
Clinical and non-contrast computed tomography characteristics and disease development in patients with benign pulmonary subsolid nodules with a solid component ≤ 5 mm
by: Shun Wu, et al.
Published: (2024-01-01)